Curie.Bio
Curie.Bio is a seed-stage biotech venture firm and drug-discovery co-pilot co-founded by Zach Weinberg (founder of Flatiron Health), Alexis Borisy, and Christoph Lengauer. It pairs seed investment — typically $5M-$7M initial checks, backed by a $380M pro-rata Series A follow-on fund — with hands-on scientific and operational support from a team of experienced drug hunters, helping therapeutics founders design their science and move programs into the clinic and toward a strong next round of financing. Curie.Bio has raised close to $1B and is backed by GV, a16z, and ARCH Venture Partners. It operates as a company/investor profile in the API Evangelist network; it publishes no public developer API or platform, so most technical API artifacts are not applicable to this provider.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Curie.Bio the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Curie.Bio scores 14.6/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
How we profile Curie.Bio
Each block below is one kind of artifact we hold for Curie.Bio. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Curie.Bio — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/curiebio · machine-readable index on apis.io